OMERS ADMINISTRATION Corp Takes $2.56 Million Position in Humana Inc. $HUM

OMERS ADMINISTRATION Corp purchased a new stake in shares of Humana Inc. (NYSE:HUM) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 6,457 shares of the insurance provider’s stock, valued at approximately $2,565,000.

A number of other hedge funds have also bought and sold shares of the business. Wilkerson Advisory Group LLC grew its stake in Humana by 24.6% in the 2nd quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock valued at $66,000 after purchasing an additional 33 shares during the period. Bogart Wealth LLC raised its stake in shares of Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after purchasing an additional 48 shares during the period. Fiduciary Alliance LLC raised its stake in shares of Humana by 0.9% during the 1st quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock worth $976,000 after purchasing an additional 49 shares during the period. Sanctuary Advisors LLC boosted its holdings in shares of Humana by 1.6% in the 4th quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock worth $868,000 after buying an additional 52 shares during the last quarter. Finally, Horizon Investments LLC boosted its holdings in shares of Humana by 2.5% in the 4th quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock worth $573,000 after buying an additional 55 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Performance

NYSE HUM opened at $388.92 on Wednesday. The firm has a market cap of $46.70 billion, a P/E ratio of 36.79, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The company’s 50 day moving average is $383.88 and its 200-day moving average is $285.00. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same period last year, the firm earned $6.27 EPS. Humana’s revenue for the quarter was up 26.2% on a year-over-year basis. Sell-side analysts predict that Humana Inc. will post 9.12 earnings per share for the current year.

Analyst Upgrades and Downgrades

HUM has been the subject of a number of research analyst reports. Barclays raised their price objective on shares of Humana from $344.00 to $407.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Wells Fargo & Company raised shares of Humana from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $227.00 to $502.00 in a report on Monday, July 13th. Royal Bank Of Canada upped their price objective on Humana from $246.00 to $415.00 and gave the company a “sector perform” rating in a research note on Thursday, July 9th. Wolfe Research reissued an “outperform” rating and issued a $450.00 target price on shares of Humana in a research report on Monday. Finally, Morgan Stanley upgraded Humana from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $249.00 to $370.00 in a research note on Tuesday, August 4th. Fourteen analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $403.91.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.